Cargando…
Dexmedetomidine enhances hypoxia-induced cancer cell progression
Dexmedetomidine (DEX) is widely used in perioperative settings for analgesia and sedation; however, little is known about its effects on the hypoxia-induced progression of tumor cells. In the present study, the effects of DEX on hypoxia-induced growth and metastasis of lung cancer cells and colorect...
Autores principales: | Chen, Hua Yan, Li, Geng Hua, Tan, Guo Cheng, Liang, Hua, Lai, Xiao Hong, Huang, Qiong, Zhong, Ji Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861874/ https://www.ncbi.nlm.nih.gov/pubmed/31772647 http://dx.doi.org/10.3892/etm.2019.8136 |
Ejemplares similares
-
Hypoxia‐induced FOXO4/LDHA axis modulates gastric cancer cell glycolysis and progression
por: Wang, Xiao‐Hong, et al.
Publicado: (2021) -
Hypoxia-induced NFATc3 deSUMOylation enhances pancreatic carcinoma progression
por: Tong, Yingying, et al.
Publicado: (2022) -
Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia
por: Yeh, Ching-Hua, et al.
Publicado: (2018) -
Effects and mechanism of dexmedetomidine on neuronal cell injury induced by hypoxia-ischemia
por: Liu, Ya-Jun, et al.
Publicado: (2017) -
Effect of Dexmedetomidine on Perioperative Hemodynamics and Myocardial Protection in Thoracoscopic-Assisted Thoracic Surgery
por: Li, Hua, et al.
Publicado: (2021)